Nova Pharma Solutions Berhad reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was MYR 6.28 million compared to MYR 4.24 million a year ago. Net income was MYR 0.482 million compared to net loss of MYR 0.649 million a year ago.

Basic earnings per share from continuing operations was MYR 0.0032 compared to basic loss per share from continuing operations of MYR 0.0044 a year ago.